share_log

Day One Biopharmaceutical Q1 2024 GAAP EPS $(0.72) Misses $(0.66) Estimate

Benzinga ·  May 6 16:33

Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.72) per share which missed the analyst consensus estimate of $(0.66) by 9.09 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment